explore -WSS

explore

author：entertainment 2025-10-01 21:36:15 - browse：6

US Capitol - SOTU — Lawmakers in Congress have decided to punt efforts to reform how PBMs operate. BRENDAN SMIALOWSKI/AFP/Getty Images

WASHINGTON — Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government, 11 lobbyists and sources following the talks told STAT.

It’s a missed opportunity to pass one of the health care priorities that has attracted the most bipartisan interest and activity this Congress, though lawmakers could revive the negotiations on the issues in the future.

Reforming how pharmacy benefit managers operate has been a top lobbying priority for the pharmaceutical industry since Democrats passed a major package aimed at lowering the costs of medicines in 2022. Pharma and PBMs have taken up a very public battle on the airwaves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Methadone treatment changes are coming. Do they go far enough?

WSS

Secretariat’s lessons for human medicine

Orchard's therapy for neuron disease in children wins FDA approval

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Methadone treatment changes are coming. Do they go far enough?

Measles policy set amid Florida outbreak alarms vaccine proponents

hotspot

explore

focus

Jerome Adams on the need for new antivirals for Covid

A new drug could help frostbite victims avoid its ravages

Continuity nursing helped my family in our darkest PICU moments

A new drug could help frostbite victims avoid its ravages

Sports medicine is finally prioritizing gender equality

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

WATCH: Why do our ears pop?

In Memoriam: Notable people who died in 2023

Readout Newsletter: Bluebird, CVS, Contineum

leisure time

Flagship Pioneering startup Sonata Therapeutics lays off 21

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Creating egg and sperm cells from stem cells raises ethical issues

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

5 to watch: Tech startups trying to solve health care's staffing crisis

Abridge raises $150m as clinical notes automation market heats up

entertainment

hotspot

hotspot

hotspot